Total Hip Arthroplasty Clinical Trial
Official title:
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery Based on Rotational Thromboelastometry (ROTEM®).
Total hip arthroplasty (THA) is associated with blood loss ranging from 300 to 2000 mL. Tranexamic acid (TXA) is frequently administered prophylactically during this procedure to reduce blood loss by inhibiting fibrinolysis or by stopping naturally occurring clot resolution. TXA is employed currently based on a surgeon's preference. The objective of this study is to quantitate the degree of fibrinolysis using rotational thromboelastometry (ROTEM) and investigate the role of TXA prophylaxis on blood loss in patients undergoing THA in a double-blind fashion. Our hypothesis is that fibrinolysis is minimal at most and TXA prophylaxis is not necessary during THA. All patients, whether they receive TXA or normal saline, will not be at risk, as at this time no data exists to determine which approach is safer or more effective. This is the first study to compare TXA vs. placebo in a double-blinded, randomized controlled trial.
Total hip arthroplasty (THA) is associated with moderate blood loss ranging from 300 to 2000 mL. Tranexamic acid (TXA) is frequently administered prophylactically during this procedure to reduce blood loss by inhibiting fibrinolysis. Most clinical studies reported potential benefit of the treatment demonstrated by less estimated blood loss (EBL), reduced hemoglobin/hematocrit (HH) change, and reduced transfused packed red blood cells (PRBC). However, bleeding complication may be affected more significantly by the degree of surgical trauma and comorbidity of patients than coagulation abnormality. Further, the frequency and severity of fibrinolysis during these procedures have not been well studied. Additionally, TXA administration may increase the tendency of postoperative venous thrombosis by inhibiting fibrinolysis in already prothrombotic patients. The objective of this study is to quantitate the degree of fibrinolysis using rotational thromboelastometry (ROTEM) and investigate the role of TXA prophylaxis on clinical outcome in patients undergoing THA in a double-blind fashion. Our hypothesis is that fibrinolysis is minimal at most and TXA prophylaxis is not necessary during primary THA. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02818894 -
Spinal Anesthesia in Total Hip Arthroplasty
|
Phase 4 | |
Completed |
NCT02242201 -
Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular
|
Phase 4 | |
Completed |
NCT02414542 -
Minima Clinical Study
|
||
Completed |
NCT01817010 -
Strength and Function Following Total Hip Arthroplasty
|
N/A | |
Completed |
NCT01443975 -
Clinical Evaluation on the Use of the X-pander Device
|
N/A | |
Recruiting |
NCT05530551 -
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
|
N/A | |
Recruiting |
NCT05530174 -
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With a Fracture
|
N/A | |
Recruiting |
NCT05054192 -
Reliability and Validity of Modified Four Square Step Test
|
||
Recruiting |
NCT06141928 -
Comparison of Three Different Surgical Approaches on the Functional Outcome After Total Hip Arthroplasty
|
N/A | |
Recruiting |
NCT04492462 -
The Impact of Two Different Physical Therapy Programs in the Rehabilitation of Patients Undergoing Anterior Approach Hip Replacement Surgery
|
N/A | |
Withdrawn |
NCT02926651 -
Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty
|
Phase 4 | |
Completed |
NCT02308813 -
Predictability of the Ability to Perform an Emergency Stop With Disorders of the Hip
|
N/A | |
Recruiting |
NCT02032017 -
Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation.
|
N/A | |
Recruiting |
NCT01312077 -
The Analgesic Efficacy of Periarticular Infiltration of Local Anaesthetic for Total Hip Replacement
|
Phase 4 | |
Withdrawn |
NCT01380665 -
Prevena™ Incision Management System Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee Arthroplasty
|
Phase 4 | |
Recruiting |
NCT05893563 -
Corail Stability at 5-Years Post-Total Hip Arthroplasty
|
||
Recruiting |
NCT06088069 -
Effect of Virtual Reality on Perioperative Anxiety, Stress and Pain in Total Hip Arthroplasty
|
N/A | |
Active, not recruiting |
NCT03210844 -
The Clinical Outcomes After Direct Anterior Approach and Microposterior Approach for Total Hip Arthroplasty
|
N/A | |
Recruiting |
NCT04801680 -
Mpact 3D Metal Cup PMS
|
||
Terminated |
NCT02006251 -
Real-Time Instrument for Acetabular Shell Positioning
|